Paul Denslow currently serves as Board Chair, CEO, and Co-Founder of Intus Bio since August 2021, and as Founder of Canford Partners since February 2018, focusing on investments, syndication, consultancy, and fundraising in the biotech and technology sectors. Additional advisory roles include positions at Modulo Bio, CytoVeris, and Quidient, with a notable emphasis on innovative 3D imaging and virtual modeling. Prior experience encompasses significant leadership roles at Standard Chartered Bank and HSBC, specializing in foreign exchange sales and capital markets. Educational background includes a Bachelor of Science in Economics from the University of Bath.
This person is not in the org chart
This person is not in any teams
This person is not in any offices